NDC 63323-386-01 - Cefotetan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-386
- Requested NDC
- 63323-386-01
- Package NDCs from labels
- 63323-386-01, 63323-386-20
- Manufacturer
- Fresenius Kabi USA, LLC | ACS DOBFAR SPA
- Effective date
- 2025-01-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cefotetan - Fresenius Kabi USA, LLC | ACS DOBFAR SPA | Fresenius Kabi USA, LLC | ACS DOBFAR SPA | 2025-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-386-01 | Cefotetan | 20 mL in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 20 | 9 | |
| 63323-386-20 | Cefotetan | 10 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 10 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-386-01 | EA - Each | 63323-386 | de9302fa-a8aa-42af-a10f-5ef9fefe1085 | 1 | 2023-03-13 |
| 63323-386-20 | EA - Each | 63323-386 | ee948f87-45e8-4603-a611-79b87641066e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEFOTETAN DISODIUM | ACTIVE INGREDIENT | 0GXP746VXB | CEFOTETAN (CEFOTETAN DISODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 | |
| CEFOTETAN | ACTIVE MOIETY | 48SPP0PA9Q | CEFOTETAN (CEFOTETAN DISODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefotetan | CEFOTETAN DISODIUM | Fresenius Kabi USA, LLC | bd22c66b-8a1c-44c8-b5b6-3ab0ce5c800e | 2025-01-08 | Warnings, Adverse reactions | ANDA065374 63323-386-20 63323-385-01 63323-386-01 63323-385-10 63323-385 63323-386 63323038601 1722919 1722921 a30c7fcf-f9c0-4b38-bfed-fbd3b1a3e2f8 bd22c66b-8a1c-44c8-b5b6-3ab0ce5c800e 0GXP746VXB |
| Cefotetan | CEFOTETAN | Hikma Pharmaceuticals USA Inc. | 33b13b93-58ce-44c7-b9a2-af3b3a333f80 | 2024-04-11 | Warnings, Adverse reactions | 1722919 1722921 |
| Cefotan | CEFOTETAN | PAI Holdings, LLC dba PAI Pharma | f1510f5e-d001-44e0-accb-27cf79fd4f9a | 2024-04-08 | Warnings, Adverse reactions | 1722919 1722921 0GXP746VXB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.